LSTM Seminar: 'Time for Typhoid' - Professor Andrew Pollard (University of Oxford)

Event 18 Jul 2017
53

Current research activities include clinical trials of new and improved vaccines for children and adults, surveillance of invasive bacterial diseases and pneumococcal vaccine impact in children in Nepal, studies of cellular and humoral immune responses to glycoconjugate and typhoid vaccines, and development of a serogroup B meningococcal vaccine.

Andrew J Pollard, FRCPCH PhD FMedSci, is a Professor of Paediatric Infection and Immunity at the University of Oxford, Director of the Oxford Vaccine Group, Fellow of St Cross College and Honorary Consultant Paediatrician at the Children’s Hospital, Oxford, UK.

He chaired the UK’s National Institute for Health and Care Excellence (NICE) meningitis guidelines development group, and the NICE topic expert group developing quality standards for management of meningitis and meningococcal septicaemia. He chairs the UK Department of Health’s Joint Committee on Vaccination and Immunisation and the European Medicines Agency scientific advisory group on vaccines and is a member of WHO’s SAGE. His research includes the design, development and clinical evaluation of vaccines including those for meningococcal disease and enteric fever and leads studies using a human challenge model of (para)typhoid. He has a particular interest in the development of B cell immunity in early childhood. He runs surveillance for invasive bacterial diseases and studies the impact of pneumococcal vaccines in children in Nepal and leads a project on burden and transmission of typhoid in Nepal, Bangladesh and Malawi. He has supervised 23 PhD students and his publications include over 300 manuscripts and books on various topics in paediatrics and infectious diseases.

This seminar will be live streamed via: http://bit.ly/LSTM-Sem-AP

A recording will be made available the following day which can be accessed here